Laboratorio Farmaceutico Erfo SpA (IT:ERFO) has released an update.
Laboratorio Farmaceutico Erfo S.p.A., listed on Euronext Growth Milan, has acquired 4,000 shares as part of its ongoing buyback plan, representing 0.04% of its share capital. This latest purchase brings their total treasury shares to 5.44% of the share capital. The company continues to focus on expanding its business lines and enhancing its nutraceutical offerings.
For further insights into IT:ERFO stock, check out TipRanks’ Stock Analysis page.